Institute of Molecular Oncology, Philipps University, 35034 Marburg, Germany.
Universities of Giessen and Marburg Lung Center (UGMLC), German Center of Lung Research (DZL), Philipps University, 35034 Marburg, Germany.
Int J Mol Sci. 2020 Dec 17;21(24):9648. doi: 10.3390/ijms21249648.
Tumor progression to a metastatic and ultimately lethal stage relies on a tumor-supporting microenvironment that is generated by reciprocal communication between tumor and stromal host cells. The tumor-stroma crosstalk is instructed by the genetic alterations of the tumor cells-the most frequent being mutations in the gene () that are clinically correlated with metastasis, drug resistance and poor patient survival. The crucial mediators of tumor-stroma communication are tumor-derived extracellular vesicles (EVs), in particular exosomes, which operate both locally within the primary tumor and in distant organs, at pre-metastatic niches as the future sites of metastasis. Here, we review how wild-type and mutant p53 proteins control the secretion, size, and especially the RNA and protein cargo of tumor-derived EVs. We highlight how EVs extend the cell-autonomous tumor suppressive activity of wild-type p53 into the tumor microenvironment (TME), and how mutant p53 proteins switch EVs into oncogenic messengers that reprogram tumor-host communication within the entire organism so as to promote metastatic tumor cell dissemination.
肿瘤进展为转移和最终致命阶段依赖于肿瘤支持的微环境,该微环境是由肿瘤和基质宿主细胞之间的相互交流产生的。肿瘤-基质的串扰由肿瘤细胞的遗传改变指导,最常见的是基因 () 的突变,这些突变与转移、耐药和患者预后不良相关。肿瘤-基质通讯的关键介质是肿瘤衍生的细胞外囊泡(EVs),特别是外泌体,它们在原发性肿瘤内以及在远处器官的转移前龛位(即转移的未来部位)中局部发挥作用。在这里,我们回顾了野生型和突变型 p53 蛋白如何控制肿瘤衍生 EVs 的分泌、大小,特别是 RNA 和蛋白质货物。我们强调了 EVs 如何将野生型 p53 的细胞自主肿瘤抑制活性扩展到肿瘤微环境(TME)中,以及突变型 p53 蛋白如何将 EVs 转化为致癌信使,从而重新编程整个生物体中的肿瘤-宿主通讯,以促进转移性肿瘤细胞的扩散。